| 24.05. | Armata Pharmaceuticals Announces First Patient Dosed in Phase 1b/2a 'diSArm' Study of A.. |  |
| 23.05. | Armata Pharmaceuticals Says First Patient Dosed in Early Trial of AP-SA02 to Treat Bloo.. | |
| 23.05. | Armata Pharmaceuticals Announces First Patient Dosed in Phase 1b/2a 'diSArm' Study of A.. | |
| 12.05. | ARMATA PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI.. | |
| 12.05. | Armata Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March.. | |
| 01.04. | Armata Pharmaceuticals Announces Closing of Second and Final Tranche of $45 Million Pri.. | |
| 31.03. | ARMATA PHARMACEUTICALS : Announces Closing of Second and Final Tranche of $45 Million Priv.. | |
| 31.03. | ARMATA PHARMACEUTICALS, INC. : Unregistered Sale of Equity Securities, Submission of Matte.. | |
| 31.03. | Armata Pharmaceuticals, Inc. announced that it has received $45 million in funding from.. | |
| 30.03. | Armata Pharmaceuticals Files Shelf on Behalf of Certain Selling Stocholders | |
| 28.03. | ARMATA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers, Financial Statem.. | |
| 28.03. | Armata Pharmaceuticals, Inc. Announces Executive Changes | |
| 28.03. | Armata Pharmaceuticals, Inc. Announces CFO Changes | |
| 18.03. | Armata Pharmaceuticals Announces Fourth Quarter and Full Year 2021 Results and Provides.. | |
| 17.03. | ARMATA PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI.. | |
| 17.03. | Armata Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 3.. | |
| 17.03. | Armata Pharmaceuticals Inc. Reports Earnings Results for the Fourth Quarter Ended Decem.. | |
| 17.03. | Armata Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt | |
| 23.02. | Armata Pharmaceuticals Announces Clearance of Investigational New Drug Application to I.. | |
| 22.02. | Armata Pharmaceuticals Gets US FDA Clearance for Non-Cystic Fibrosis Bronchiectasis Tre.. | |
| 22.02. | Armata Pharmaceuticals, Inc. Announces Clearance of Investigational New Drug Applicatio.. | |
| 18.02. | Armata Pharmaceuticals to Participate in Two Upcoming Investor Conferences | |
| 11.02. | ARMATA PHARMACEUTICALS : Announces $45 Million Investment to Support Advancement of the Co.. | |
| 11.02. | ARMATA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Unregistered Sa.. | |
| 10.02. | Armata Pharmaceuticals Announces $45 Million Investment to Support Advancement of the C.. | |
| 09.02. | Armata Pharmaceuticals Inc. announced that it expects to receive $45 million in funding.. | |
| 05.01. | ARMATA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Other Events, Financial Statement.. | |
| 05.01. | Armata Pharmaceuticals Provides Update on Pseudomonas Respiratory Programs | |
| 2021 | Armata Cleared by US FDA to Start Trial of Staphylococcus Aureus Bacteremia Treatment; .. | |
| 2021 | Armata Pharmaceuticals Provides Regulatory and Clinical Update Reflecting Sustained Pro.. | |
| 2021 | Armata Pharmaceuticals Announces Third Quarter Results and Provides General Corporate U.. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI.. | |
| 2021 | Armata Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Mon.. | |
| 2021 | Armata Pharmaceuticals to Present at the 2021 World Antimicrobial Resistance Congress | |
| 2021 | Square foot facility in Los Angeles enables a substantial increase in manufacturing sca.. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Other Events, F.. | |
| 2021 | Armata Pharmaceuticals Inc. Enters Lease to Build State-Of-The-Art R&D and GMP Manufact.. | |
| 2021 | Funds to be used to further advance development of lead candidate AP-PA02, which is bei.. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Unregistered Sa.. | |
| 2021 | Armata Pharmaceuticals Secures $7 Million Investment From Cystic Fibrosis Foundation, I.. | |
| 2021 | Cystic Fibrosis Foundation Makes Equity Investment in Armata Pharmaceuticals | |
| 2021 | Top Premarket Decliners | |
| 2021 | ARMATA PHARMACEUTICALS : to Participate in the H.C. Wainwright 23rd Annual Global Investme.. | |
| 2021 | ARMATA PHARMACEUTICALS : Announces Second Quarter Results and Provides General Corporate U.. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K) | |
| 2021 | ARMATA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R.. | |
| 2021 | Armata Pharmaceuticals Inc. Announces Unaudited Consolidated Earnings Results for the S.. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K) | |
| 2021 | Armata Pharmaceuticals Inc. Appoints Brian Varnum as Member of its Board of Directors | |
| 2021 | ARMATA PHARMACEUTICALS : Announces Chief Executive Officer Transition | |
| 2021 | ARMATA PHARMACEUTICALS : Says CEO Retiring; Successor Named | |
| 2021 | Armata Pharmaceuticals Inc. Announces Executive Changes | |
| 2021 | ARMATA PHARMACEUTICALS : to Present at the Ladenburg Thalmann 2021 Healthcare Conference | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Other .. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Results of Operations and Financial Condition (form 8-K) | |
| 2021 | ARMATA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R.. | |
| 2021 | Armata Pharmaceuticals Inc. Provides Unaudited Consolidated Earnings Results for the Qu.. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Change in Directors or Principal Officers (form 8-K) | |
| 2021 | ARMATA PHARMACEUTICALS : Announces Fourth Quarter and Full Year 2020 Results and Provides .. | |
| 2021 | ARMATA PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND R.. | |
| 2021 | Armata Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 3.. | |
| 2021 | ARMATA PHARMACEUTICALS : Announces Closing of Second and Final Tranche of $20 Million Priv.. | |
| 2021 | Armata Pharmaceuticals Inc. Auditor Raises 'Going Concern' Doubt | |
| 2021 | INSIDER TRENDS : 90-Day Buying Trend Extended with Insider Purchase of Armata Pharmaceutic.. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Unregistered Sale of Equity Securities, Submission of Matte.. | |
| 2021 | ARMATA PHARMACEUTICALS : to Present at the Oppenheimer 31st Annual Healthcare Conference | |
| 2021 | INSIDER TRENDS : 90-Day Insider Selling Trend at Armata Pharmaceuticals Slowed with Acquis.. | |
| 2021 | ARMATA PHARMACEUTICALS : Announces $20 Million Investment to Support Advancement of the Co.. | |
| 2021 | SECTOR UPDATE : Health Care Stocks Ending Near Wednesday Session Lows | |
| 2021 | SECTOR UPDATE : Health Care Stocks Still on Steep Slide | |
| 2021 | ARMATA PHARMACEUTICALS : to Sell $20 Million in Stock, Warrants to Largest Shareholder | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Entry into a Material Definitive Agreement, Unregistered Sa.. | |
| 2021 | ARMATA PHARMACEUTICALS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits.. | |
| 2020 | ARMATA PHARMACEUTICALS, INC. : Submission of Matters to a Vote of Security Holders, Other .. | |
| 2020 | Armata Pharmaceuticals, Inc. Announces Board Changes | |
English (USA)
English (UK)
English (Canada)
Deutsch (Deutschland)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
Bericht
